Related references
Note: Only part of the references are listed.Proteolytic Origin of the Soluble Human IL-6R In Vivo and a Decisive Role of N-Glycosylation
Steffen Riethmueller et al.
PLOS BIOLOGY (2017)
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
Michael A. Gimbrone et al.
CIRCULATION RESEARCH (2016)
Interleukin-6: Biology, signaling and strategies of blockade
Fred Schaper et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Shedding of Endogenous Interleukin-6 Receptor (IL-6R) Is Governed by A Disintegrin and Metalloproteinase (ADAM) Proteases while a Full-length IL-6R Isoform Localizes to Circulating Microvesicles
Neele Schumacher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Intersection of mTOR and STAT signaling in immunity
Diana Saleiro et al.
TRENDS IN IMMUNOLOGY (2015)
Interleukin-6 and its receptors: A highly regulated and dynamic system
Janina Wolf et al.
CYTOKINE (2014)
Gene of the month: Interleukin 6 (IL-6)
Parvin Ataie-Kachoie et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
Xin Yao et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Targeting Interleukin-6 in Rheumatoid Arthritis
Md Yuzaiful Md Yusof et al.
DRUGS (2013)
Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation
M. Leibinger et al.
CELL DEATH & DISEASE (2013)
Interleukin-6 signalling: More than Jaks and STATs
Rene Eulenfeld et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2012)
Biology and significance of the JAK/STAT signalling pathways
Hiu Kiu et al.
GROWTH FACTORS (2012)
IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6
Stefan Rose-John
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
Targeting Interleukin-6: All the Way to Treat Autoimmune and Inflammatory Diseases
Toshio Tanaka et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Juergen Scheller et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Integrated safety in tocilizumab clinical trials
Michael H. Schiff et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Monocyte Chemoattractant Protein-1 Deficiency Protects Against Visceral Fat-Induced Atherosclerosis
Miina K. Oehman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Anti-inflammatory mechanism of tocilizumab, a humanized anti-IL-6R antibody: effect on the expression of chemokine and adhesion molecule
Miho Suzuki et al.
RHEUMATOLOGY INTERNATIONAL (2010)
Cholinergic agonists regulate JAK2/STAT3 signaling to suppress endothelial cell activation
Prodyot K. Chatterjee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Signal Transducer and Activator of Transcription 3 (STAT3) Mediates Amino Acid Inhibition of Insulin Signaling through Serine 727 Phosphorylation
Jeong-Ho Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Atheroprotective role of interleukin-6 in diet- and/or pathogen-associated atherosclerosis using an ApoE heterozygote murine model
Monika Madan et al.
ATHEROSCLEROSIS (2008)
Prostaglndin E1 inhibits IL-6-induced MCM expression by interfering specifically in IL-6-dependent ERK1/2, but not STAT3, activation
Radoslaw M. Sobota et al.
BIOCHEMICAL JOURNAL (2008)
Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway
Jeong-Ho Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
ICAM-1 induction by TNF alpha and IL-6 is mediated by distinct pathways via Rac in endothelial cells
BS Wung et al.
JOURNAL OF BIOMEDICAL SCIENCE (2005)
IL-6 induces NF-κB activation in the intestinal epithelia
LX Wang et al.
JOURNAL OF IMMUNOLOGY (2003)
SOCS3 regulates the plasticity of gp130 signaling
R Lang et al.
NATURE IMMUNOLOGY (2003)
The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex
SA Jones et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2002)
Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR
K Yokogami et al.
CURRENT BIOLOGY (2000)
Share Paper
